Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
39
LSAK Quote, Financials, Valuation and Earnings
Last price:
$4.62
Seasonality move
:
9.24%
Day range:
$4.56 - $4.72
52-week range:
$3.39 - $5.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.56x
P/B ratio:
2.28x
Volume:
46K
Avg. volume:
57.6K
1-year change:
-9.77%
Market cap:
$388.5M
Revenue:
$659.7M
EPS (TTM):
-$1.07
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $130.8M | $222.6M | $528M | $564.2M | $659.7M | |
| Revenue Growth (YoY) | -9.37% | 70.21% | 137.17% | 6.87% | 16.92% | |
| Cost of Revenues | $100.6M | $175.9M | $441.2M | $466.3M | $520.3M | |
| Gross Profit | $30.2M | $46.7M | $86.7M | $97.9M | $139.4M | |
| Gross Profit Margin | 23.08% | 20.99% | 16.43% | 17.35% | 21.14% | |
| R&D Expenses | $300K | $500K | $500K | $500K | $500K | |
| Selling, General & Admin | $84.1M | $75M | $95.1M | $92M | $131.5M | |
| Other Inc / (Exp) | $48.8M | -$7.9M | -$7.2M | -$2.3M | -- | |
| Operating Expenses | $84.1M | $75M | $95.1M | $91.8M | $131.5M | |
| Operating Income | -$53.9M | -$28.3M | -$8.3M | $6.1M | $7.9M | |
| Net Interest Expenses | $3M | $5.8M | $18.6M | $18.9M | $21.5M | |
| EBT. Incl. Unusual Items | -$5.6M | -$39.9M | -$32.3M | -$12.8M | -$105.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.6M | $327K | -$2.3M | $3.4M | -$18.2M | |
| Net Income to Company | -$38.1M | -$43.9M | -$35.1M | -$17.4M | -$87.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$130K | |
| Net Income to Common Excl Extra Items | -$37.8M | -$43M | -$33.4M | -$16.7M | -$84.7M | |
| Basic EPS (Cont. Ops) | -$0.67 | -$0.75 | -$0.56 | -$0.27 | -$1.14 | |
| Diluted EPS (Cont. Ops) | -$0.67 | -$0.75 | -$0.56 | -$0.27 | -$1.14 | |
| Weighted Average Basic Share | $56.3M | $57.2M | $60.1M | $61.3M | $73.9M | |
| Weighted Average Diluted Share | $56.3M | $57.2M | $60.1M | $61.3M | $73.9M | |
| EBITDA | -$49.5M | -$20.7M | $15.4M | $29.8M | $41.6M | |
| EBIT | -$53.9M | -$28.3M | -$8.3M | $6.1M | $7.9M | |
| Revenue (Reported) | $130.8M | $222.6M | $528M | $564.2M | $659.7M | |
| Operating Income (Reported) | -$53.9M | -$28.3M | -$8.3M | $6.1M | $7.9M | |
| Operating Income (Adjusted) | -$53.9M | -$28.3M | -$8.3M | $6.1M | $7.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $34.5M | $124.8M | $136.1M | $145.5M | $171.4M | |
| Revenue Growth (YoY) | -7.03% | 261.66% | 9.06% | 6.95% | 17.8% | |
| Cost of Revenues | $25.1M | $106.5M | $113.3M | $117.2M | $131.3M | |
| Gross Profit | $9.4M | $18.3M | $22.7M | $28.4M | $40.1M | |
| Gross Profit Margin | 27.25% | 14.63% | 16.71% | 19.5% | 23.4% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.6M | $22.9M | $22.5M | $26.7M | $39.6M | |
| Other Inc / (Exp) | -$185K | $248K | -- | -$1.7M | -- | |
| Operating Expenses | $20.6M | $22.9M | $22.3M | $26.7M | $39.6M | |
| Operating Income | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Net Interest Expenses | $816K | $4M | $4.9M | $5M | $4.9M | |
| EBT. Incl. Unusual Items | -$11.7M | -$8M | -$4M | -$4.5M | -$4.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $186K | $31K | $264K | $78K | -$146K | |
| Net Income to Company | -$13M | -$10.7M | -$5.7M | -$4.5M | -$4.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$117K | |
| Net Income to Common Excl Extra Items | -$12.9M | -$10.3M | -$5.4M | -$4.4M | -$4.3M | |
| Basic EPS (Cont. Ops) | -$0.23 | -$0.17 | -$0.09 | -$0.07 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.23 | -$0.17 | -$0.09 | -$0.07 | -$0.05 | |
| Weighted Average Basic Share | $56.3M | $60M | $61M | $62.3M | $79.1M | |
| Weighted Average Diluted Share | $56.3M | $60M | $61M | $62.3M | $79.1M | |
| EBITDA | -$10.3M | $1.3M | $6.3M | $7.9M | $13.4M | |
| EBIT | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Revenue (Reported) | $34.5M | $124.8M | $136.1M | $145.5M | $171.4M | |
| Operating Income (Reported) | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Operating Income (Adjusted) | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $130.2M | $312.9M | $539.3M | $573.7M | $651.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $98.3M | $257.3M | $448M | $470.2M | $500.6M | |
| Gross Profit | $31.8M | $55.6M | $91.2M | $103.5M | $151.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $86.2M | $77.5M | $94.6M | $96.2M | $144.7M | |
| Other Inc / (Exp) | $48.6M | -$7.5M | -$7.5M | -$4M | -- | |
| Operating Expenses | $86.2M | $77.5M | $94.4M | $96.2M | $144.7M | |
| Operating Income | -$54.3M | -$21.9M | -$3.2M | $7.3M | $6.5M | |
| Net Interest Expenses | $3.1M | $9M | $19.4M | $19.1M | $21.3M | |
| EBT. Incl. Unusual Items | -$6.4M | -$36.3M | -$28.2M | -$13.3M | -$106M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.8M | $172K | -$2.1M | $3.2M | -$18.4M | |
| Net Income to Company | -$25.6M | -$40.5M | -$28.3M | -$16.5M | -$87M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$247K | |
| Net Income to Common Excl Extra Items | -$22.1M | -$40.5M | -$28.7M | -$15.7M | -$84.7M | |
| Basic EPS (Cont. Ops) | -$0.39 | -$0.68 | -$0.46 | -$0.25 | -$1.07 | |
| Diluted EPS (Cont. Ops) | -$0.39 | -$0.68 | -$0.46 | -$0.25 | -$1.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$50M | -$9.3M | $20.4M | $31.4M | $46.8M | |
| EBIT | -$54.3M | -$21.9M | -$3.2M | $7.3M | $6.5M | |
| Revenue (Reported) | $130.2M | $312.9M | $539.3M | $573.7M | $651.8M | |
| Operating Income (Reported) | -$54.3M | -$21.9M | -$3.2M | $7.3M | $6.5M | |
| Operating Income (Adjusted) | -$54.3M | -$21.9M | -$3.2M | $7.3M | $6.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $34.5M | $124.8M | $136.1M | $145.5M | $171.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $25.1M | $106.5M | $113.3M | $117.2M | $131.3M | |
| Gross Profit | $9.4M | $18.3M | $22.7M | $28.4M | $40.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $20.6M | $22.9M | $22.5M | $26.7M | $39.6M | |
| Other Inc / (Exp) | -$185K | $248K | -- | -$1.7M | -- | |
| Operating Expenses | $20.6M | $22.9M | $22.3M | $26.7M | $39.6M | |
| Operating Income | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Net Interest Expenses | $816K | $4M | $4.9M | $5M | $4.9M | |
| EBT. Incl. Unusual Items | -$11.7M | -$8M | -$4M | -$4.5M | -$4.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $186K | $31K | $264K | $78K | -$146K | |
| Net Income to Company | -$13M | -$10.7M | -$5.7M | -$4.5M | -$4.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$117K | |
| Net Income to Common Excl Extra Items | -$12.9M | -$10.3M | -$5.4M | -$4.4M | -$4.3M | |
| Basic EPS (Cont. Ops) | -$0.23 | -$0.17 | -$0.09 | -$0.07 | -$0.05 | |
| Diluted EPS (Cont. Ops) | -$0.23 | -$0.17 | -$0.09 | -$0.07 | -$0.05 | |
| Weighted Average Basic Share | $56.3M | $60M | $61M | $62.3M | $79.1M | |
| Weighted Average Diluted Share | $56.3M | $60M | $61M | $62.3M | $79.1M | |
| EBITDA | -$10.3M | $1.3M | $6.3M | $7.9M | $13.4M | |
| EBIT | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Revenue (Reported) | $34.5M | $124.8M | $136.1M | $145.5M | $171.4M | |
| Operating Income (Reported) | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Operating Income (Adjusted) | -$11.2M | -$4.7M | $478K | $1.7M | $477K | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $223.8M | $104.8M | $58.6M | $65.9M | $76.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $10.5M | $13.9M | $11M | $13.3M | $16.4M | |
| Inventory | $22.4M | $34.2M | $27.3M | $18.2M | $23.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $466K | $15.9M | $15.3M | $22.8M | -- | |
| Total Current Assets | $294.3M | $217.7M | $163.6M | $187.7M | $243.9M | |
| Property Plant And Equipment | $12M | $31.7M | $32.2M | $39.2M | $54.6M | |
| Long-Term Investments | $90.2M | $82.2M | $79.5M | $76.5M | $199K | |
| Goodwill | $29.2M | $162.7M | $133.7M | $138.6M | -- | |
| Other Intangibles | $357K | $156.7M | $121.6M | $111.4M | -- | |
| Other Long-Term Assets | $1.3M | $1.4M | $1M | $1.5M | -- | |
| Total Assets | $428.3M | $656.6M | $542.2M | $558.5M | $653.7M | |
| Accounts Payable | $7.1M | $18.6M | $12.4M | $16.7M | $19.9M | |
| Accrued Expenses | $7.5M | $9.9M | -- | $7.2M | -- | |
| Current Portion Of Long-Term Debt | -- | $6.8M | $3.7M | $3.9M | -- | |
| Current Portion Of Capital Lease Obligations | $2.8M | $2.5M | $1.7M | $2.3M | -- | |
| Other Current Liabilities | $466K | $15.3M | $14.8M | $22.4M | -- | |
| Total Current Liabilities | $52.5M | $145.9M | $101.9M | $118M | $160.5M | |
| Long-Term Debt | $1.9M | $139.7M | $132.6M | $144.4M | $194.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $67.4M | $342.2M | $283.3M | $303.2M | $392.3M | |
| Common Stock | $80K | $83K | $83K | $83K | $103K | |
| Other Common Equity Adj | -$145.7M | -$168.8M | -$195.7M | -$188.4M | -- | |
| Common Equity | $276M | $234.9M | $179.5M | $175.9M | $165.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $6.8M | |
| Total Equity | $361M | $314.3M | $258.9M | $255.3M | $261.4M | |
| Total Liabilities and Equity | $428.3M | $656.6M | $542.2M | $558.5M | $653.7M | |
| Cash and Short Terms | $223.8M | $104.8M | $58.6M | $65.9M | $76.6M | |
| Total Debt | $1.9M | $146.5M | $136.3M | $148.3M | $206.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $250.4M | $93.4M | $55M | $49.8M | $72.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $8M | $12.3M | $10.2M | $11.1M | $22.1M | |
| Inventory | $19.6M | $31.2M | $27.8M | $20.2M | $19M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $466K | $16.3M | $26.4M | $20.5M | -- | |
| Total Current Assets | $318.8M | $203.7M | $172.8M | $167.3M | $240.5M | |
| Property Plant And Equipment | $10.6M | $30.3M | $33.3M | $41.9M | $56.2M | |
| Long-Term Investments | $83.9M | $81.4M | $78.6M | $76.5M | $170K | |
| Goodwill | $27.6M | $147.2M | $133.1M | $146.6M | -- | |
| Other Intangibles | $321K | $138M | $117.6M | $114.1M | -- | |
| Other Long-Term Assets | $1.2M | $1.3M | $1.3M | $1.5M | -- | |
| Total Assets | $443.8M | $605.8M | $546.8M | $551.9M | $652.9M | |
| Accounts Payable | $4.3M | $19.3M | $13.6M | $12.8M | $19.1M | |
| Accrued Expenses | $7.8M | $7.1M | $6.6M | $10M | -- | |
| Current Portion Of Long-Term Debt | -- | $6.4M | $3.6M | $3.8M | -- | |
| Current Portion Of Capital Lease Obligations | $2.7M | $1.8M | $1.7M | $2.6M | -- | |
| Other Current Liabilities | $466K | $15.8M | $25.4M | $19.9M | -- | |
| Total Current Liabilities | $87.7M | $143.5M | $109.4M | $96.5M | $149.3M | |
| Long-Term Debt | $1.4M | $125.8M | $134.7M | $149.6M | $201.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $102M | $320.5M | $292.1M | $288.2M | $386.6M | |
| Common Stock | $80K | $83K | $83K | $83K | $103K | |
| Other Common Equity Adj | -$152.3M | -$188.5M | -$196.1M | -$177.8M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $6.9M | |
| Total Equity | $341.7M | $285.3M | $254.7M | $263.6M | $266.2M | |
| Total Liabilities and Equity | $443.8M | $605.8M | $546.8M | $551.9M | $652.9M | |
| Cash and Short Terms | $250.4M | $93.4M | $55M | $49.8M | $72.3M | |
| Total Debt | $1.4M | $132.1M | $138.3M | $153.5M | $214.1M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$38.1M | -$43.9M | -$35.1M | -$17.4M | -$87.6M | |
| Depreciation & Amoritzation | $4.3M | $7.6M | $23.7M | $23.7M | $33.7M | |
| Stock-Based Compensation | $344K | $3M | $7.3M | $7.9M | $9.6M | |
| Change in Accounts Receivable | $3.8M | $9.1M | -$14M | -$20.9M | -$33.5M | |
| Change in Inventories | $1.3M | -$4.8M | $2.2M | $9.8M | $169K | |
| Cash From Operations | -$58.4M | -$37.2M | $410K | $28.8M | -$9.1M | |
| Capital Expenditures | $4.3M | $4.6M | $16.6M | $13M | $21.1M | |
| Cash Acquisitions | -- | $202.2M | -- | $1.6M | $12.9M | |
| Cash From Investing | $47.8M | -$193.7M | -$16.5M | -$16.4M | -$11.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $360.1M | $649.7M | $544.4M | $206.7M | -- | |
| Long-Term Debt Repaid | -$365.4M | -$531M | -$564.8M | -$219.7M | -- | |
| Repurchase of Common Stock | -- | -- | $1.3M | $1.5M | $13.7M | |
| Other Financing Activities | -$7.8M | $2.8M | $2M | $7.2M | -- | |
| Cash From Financing | -$13.1M | $122.3M | -$19.1M | -$7.1M | $29.7M | |
| Beginning Cash (CF) | $223.8M | $104.8M | $58.6M | $65.9M | $76.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$8.7M | -$119M | -$46.2M | $7.3M | $10.7M | |
| Ending Cash (CF) | $230M | -$24.5M | $1.5M | $75.2M | $88.8M | |
| Levered Free Cash Flow | -$62.7M | -$41.8M | -$16.2M | $15.8M | -$30.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13M | -$10.7M | -$5.7M | -$4.5M | -$4.4M | |
| Depreciation & Amoritzation | $895K | $6M | $5.9M | $6.3M | $12.9M | |
| Stock-Based Compensation | $309K | $1.5M | $1.8M | $2.4M | $1.9M | |
| Change in Accounts Receivable | $1.2M | -$6.5M | -$2.8M | $6.1M | -$8.1M | |
| Change in Inventories | $1.6M | -$279K | -$479K | -$889K | $5.1M | |
| Cash From Operations | -$7.9M | -$7.7M | $3.4M | -$4.1M | $8.9M | |
| Capital Expenditures | $698K | $4.5M | $2.9M | $4.1M | $5.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$467K | -$5.7M | -$13.9M | $282K | -$461K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $138.9M | $147.1M | $62M | $24.7M | -- | |
| Long-Term Debt Repaid | -$98.9M | -$138.5M | -$65.4M | -$36.5M | -- | |
| Repurchase of Common Stock | -- | $185K | -- | -- | -- | |
| Other Financing Activities | -- | $2M | $10.7M | -$3.6M | -- | |
| Cash From Financing | $40M | $10.4M | $7.3M | -$15.5M | -$14.7M | |
| Beginning Cash (CF) | $250.4M | $93.4M | $55M | $49.8M | $72.3M | |
| Foreign Exchange Rate Adjustment | -$4.9M | -$8.5M | -$443K | $3.2M | $1.9M | |
| Additions / Reductions | $26.7M | -$11.4M | -$3.6M | -$16.1M | -$4.4M | |
| Ending Cash (CF) | $272.2M | $73.5M | $50.9M | $36.9M | $69.9M | |
| Levered Free Cash Flow | -$8.6M | -$12.2M | $430K | -$8.3M | $3.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$25.6M | -$40.5M | -$28.3M | -$16.5M | -$87M | |
| Depreciation & Amoritzation | $4.7M | $12.5M | $22.4M | $24.3M | $40.1M | |
| Stock-Based Compensation | $285.6K | $4M | $7.2M | $8.6M | $9M | |
| Change in Accounts Receivable | $13.4M | $1.1M | -$9.7M | -$12.1M | -$47.6M | |
| Change in Inventories | $620.7K | -$6.6M | $1.9M | $9.5M | $6.2M | |
| Cash From Operations | -$41.8M | -$36M | $11.4M | $21.5M | $4M | |
| Capital Expenditures | $5.1M | $8.2M | $14.2M | $14.2M | $22M | |
| Cash Acquisitions | -- | -- | -- | $1.6M | $12.9M | |
| Cash From Investing | $27.5M | -$194.1M | -$23.8M | -$2.4M | -$12M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $429.8M | $657.9M | $459.3M | $169.3M | -- | |
| Long-Term Debt Repaid | -$387.5M | -$570.6M | -$491.7M | -$190.8M | -- | |
| Repurchase of Common Stock | -- | $185K | $1M | $1.5M | $13.6M | |
| Other Financing Activities | -- | $4.8M | $10.8M | -$7.1M | -- | |
| Cash From Financing | $37.4M | $89.6M | -$21.3M | -$30M | $30.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $33.7M | -$154.1M | -$36.1M | -$5.1M | $22.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$46.9M | -$44.2M | -$2.8M | $7.2M | -$18M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13M | -$10.7M | -$5.7M | -$4.5M | -$4.4M | |
| Depreciation & Amoritzation | $895K | $6M | $5.9M | $6.3M | $12.9M | |
| Stock-Based Compensation | $309K | $1.5M | $1.8M | $2.4M | $1.9M | |
| Change in Accounts Receivable | $1.2M | -$6.5M | -$2.8M | $6.1M | -$8.1M | |
| Change in Inventories | $1.6M | -$279K | -$479K | -$889K | $5.1M | |
| Cash From Operations | -$7.9M | -$7.7M | $3.4M | -$4.1M | $8.9M | |
| Capital Expenditures | $698K | $4.5M | $2.9M | $4.1M | $5.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$467K | -$5.7M | -$13.9M | $282K | -$461K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $138.9M | $147.1M | $62M | $24.7M | -- | |
| Long-Term Debt Repaid | -$98.9M | -$138.5M | -$65.4M | -$36.5M | -- | |
| Repurchase of Common Stock | -- | $185K | -- | -- | -- | |
| Other Financing Activities | -- | $2M | $10.7M | -$3.6M | -- | |
| Cash From Financing | $40M | $10.4M | $7.3M | -$15.5M | -$14.7M | |
| Beginning Cash (CF) | $250.4M | $93.4M | $55M | $49.8M | $72.3M | |
| Foreign Exchange Rate Adjustment | -$4.9M | -$8.5M | -$443K | $3.2M | $1.9M | |
| Additions / Reductions | $26.7M | -$11.4M | -$3.6M | -$16.1M | -$4.4M | |
| Ending Cash (CF) | $272.2M | $73.5M | $50.9M | $36.9M | $69.9M | |
| Levered Free Cash Flow | -$8.6M | -$12.2M | $430K | -$8.3M | $3.8M | |
Related Companies
Get LSAK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
LSAK
Sector
P/E ratio
--
12.32x
PEG ratio
-0.01x
0.31x
P/B ratio
2.28x
1.12x
Price / LTM sales
0.56x
1.83x
Growth Metrics
LSAK
Sector
Revenue growth
17.8%
5.36%
Earnings growth
25.21%
14.24%
Revenue (5-year growth)
35.52%
8.79%
Earnings forecast
$0.04
$0.64
Profitability
LSAK
Sector
Profitability FY 2025
$139.4M
--
Return on invested capital
-17.42%
4.96%
Return on assets
-13.45%
1%
Return on equity
-31.1%
9.65%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
LSAK
Sector
Total cash
$72.3M
$412.1M
Short term investments
--
$193.9M
Total assets
$653.7M
$3B
Long term debt
$214.1M
$75.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 15
Argan, Inc. [AGX] is down 0% over the past day.
Buy
80
ASTS alert for Jan 15
AST Spacemobile, Inc. [ASTS] is down 0% over the past day.
Buy
84
IREN alert for Jan 15
IREN Ltd. [IREN] is down 0% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
